Loading…
Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential
Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumo...
Saved in:
Published in: | The Journal of biological chemistry 2003-05, Vol.278 (18), p.15958-15965 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33 |
---|---|
cites | cdi_FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33 |
container_end_page | 15965 |
container_issue | 18 |
container_start_page | 15958 |
container_title | The Journal of biological chemistry |
container_volume | 278 |
creator | Lin, Ding-Yen Lai, Ming-Zong Ann, David K. Shih, Hsiu-Ming |
description | Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumor virus promoter in COS-1, HeLa, and 293T cells. In vitro and in vivo studies revealed that Daxx could directly bind to GR. The mapping analysis further demonstrated that the C-terminal region of Daxx-(501–740) mediates the interaction and transcriptional repression of GR. The repressive effect of Daxx and Daxx-(501–740) on GR could be alleviated by co-expression of promyelocytic leukemia protein (PML). Furthermore, immunofluorescence analysis showed that overexpression of wild-type PML results in the translocation of Daxx and Daxx-(501–740) to the PML oncogenic domains (PODs). By contrast, a PML sumoylation-defective mutant failed to recruit Daxx to PODs and to reverse the Daxx repression effect on GR. Accordingly, As2O3 treatment rendered the sequestration of endogenous Daxx to the PODs, leading to an enhancement of GR transactivation in COS-1 cells. Taken together, these findings suggest that recruitment of Daxx into the subnuclear POD structures sequesters it from the GR/co-activators complex, thereby alleviating its repressive effects. Our present studies provide the important link between Daxx/PML interaction and GR transcriptional activation. |
doi_str_mv | 10.1074/jbc.M300387200 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73213204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925819582849</els_id><sourcerecordid>73213204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33</originalsourceid><addsrcrecordid>eNqFkUtvEzEUhS0EoqGwZYm8QKhdTLA9zyxR0peUKhEUiZ3l8dzJuMzYwfaU5q_x63pDInWFsCxZtr5z7vU9hLznbMpZmX2-r_X0NmUsrUrB2Asy4axKkzTnP16SCWOCJzORVyfkTQj3DFc246_JCRf5LM9FMSF_1t4NO-id3kWj6RLGnzAYRfE5grH0bH27PKeXo9XROBuowk2v-lE77TwqnGnoV9Cwjc7TuUsUcg9qf6l39Bv8GiFE8MZu6EI9PtLoaOyAoildWe02YLHowg3KoPfZerUI53vmwnbKaqA3MdA7r2w42mILdI2N2WhU_5a8alUf4N3xPCXfLy_u5tfJcnV1M_-yTHTOipgUDNJWzErgDeNZplqVlWnLa80qKETWlG3NOWgcVdroVhVtVagMWs5Fo2eiTtNT8ungu_Xu73_kYIKGvlcW3BhkmaJUsOy_IK8QLYq94_QAau9C8NDKrTeD8jvJmdzHKjFW-RwrCj4cncd6gOYZP-aIwMcD0JlN99t4kLVxuoNBirLCwpIjWCFWHTDAeT0Y8DJoAzjpBiU6ysaZf7XwBDjuvyI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18732663</pqid></control><display><type>article</type><title>Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential</title><source>ScienceDirect (Online service)</source><creator>Lin, Ding-Yen ; Lai, Ming-Zong ; Ann, David K. ; Shih, Hsiu-Ming</creator><creatorcontrib>Lin, Ding-Yen ; Lai, Ming-Zong ; Ann, David K. ; Shih, Hsiu-Ming</creatorcontrib><description>Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumor virus promoter in COS-1, HeLa, and 293T cells. In vitro and in vivo studies revealed that Daxx could directly bind to GR. The mapping analysis further demonstrated that the C-terminal region of Daxx-(501–740) mediates the interaction and transcriptional repression of GR. The repressive effect of Daxx and Daxx-(501–740) on GR could be alleviated by co-expression of promyelocytic leukemia protein (PML). Furthermore, immunofluorescence analysis showed that overexpression of wild-type PML results in the translocation of Daxx and Daxx-(501–740) to the PML oncogenic domains (PODs). By contrast, a PML sumoylation-defective mutant failed to recruit Daxx to PODs and to reverse the Daxx repression effect on GR. Accordingly, As2O3 treatment rendered the sequestration of endogenous Daxx to the PODs, leading to an enhancement of GR transactivation in COS-1 cells. Taken together, these findings suggest that recruitment of Daxx into the subnuclear POD structures sequesters it from the GR/co-activators complex, thereby alleviating its repressive effects. Our present studies provide the important link between Daxx/PML interaction and GR transcriptional activation.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M300387200</identifier><identifier>PMID: 12595526</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adaptor Proteins, Signal Transducing ; Animals ; Arsenic Trioxide ; Arsenicals - pharmacology ; Carrier Proteins - chemistry ; Carrier Proteins - physiology ; Co-Repressor Proteins ; COS Cells ; HeLa Cells ; Humans ; Intracellular Signaling Peptides and Proteins ; Mammary Tumor Virus, Mouse - genetics ; Molecular Chaperones ; Neoplasm Proteins - physiology ; Nuclear Proteins - chemistry ; Nuclear Proteins - physiology ; Oxides - pharmacology ; Promoter Regions, Genetic ; Promyelocytic Leukemia Protein ; Receptors, Glucocorticoid - physiology ; Transcription Factors - physiology ; Transcriptional Activation ; Tumor Suppressor Proteins</subject><ispartof>The Journal of biological chemistry, 2003-05, Vol.278 (18), p.15958-15965</ispartof><rights>2003 © 2003 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33</citedby><cites>FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021925819582849$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12595526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, Ding-Yen</creatorcontrib><creatorcontrib>Lai, Ming-Zong</creatorcontrib><creatorcontrib>Ann, David K.</creatorcontrib><creatorcontrib>Shih, Hsiu-Ming</creatorcontrib><title>Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumor virus promoter in COS-1, HeLa, and 293T cells. In vitro and in vivo studies revealed that Daxx could directly bind to GR. The mapping analysis further demonstrated that the C-terminal region of Daxx-(501–740) mediates the interaction and transcriptional repression of GR. The repressive effect of Daxx and Daxx-(501–740) on GR could be alleviated by co-expression of promyelocytic leukemia protein (PML). Furthermore, immunofluorescence analysis showed that overexpression of wild-type PML results in the translocation of Daxx and Daxx-(501–740) to the PML oncogenic domains (PODs). By contrast, a PML sumoylation-defective mutant failed to recruit Daxx to PODs and to reverse the Daxx repression effect on GR. Accordingly, As2O3 treatment rendered the sequestration of endogenous Daxx to the PODs, leading to an enhancement of GR transactivation in COS-1 cells. Taken together, these findings suggest that recruitment of Daxx into the subnuclear POD structures sequesters it from the GR/co-activators complex, thereby alleviating its repressive effects. Our present studies provide the important link between Daxx/PML interaction and GR transcriptional activation.</description><subject>Adaptor Proteins, Signal Transducing</subject><subject>Animals</subject><subject>Arsenic Trioxide</subject><subject>Arsenicals - pharmacology</subject><subject>Carrier Proteins - chemistry</subject><subject>Carrier Proteins - physiology</subject><subject>Co-Repressor Proteins</subject><subject>COS Cells</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Mammary Tumor Virus, Mouse - genetics</subject><subject>Molecular Chaperones</subject><subject>Neoplasm Proteins - physiology</subject><subject>Nuclear Proteins - chemistry</subject><subject>Nuclear Proteins - physiology</subject><subject>Oxides - pharmacology</subject><subject>Promoter Regions, Genetic</subject><subject>Promyelocytic Leukemia Protein</subject><subject>Receptors, Glucocorticoid - physiology</subject><subject>Transcription Factors - physiology</subject><subject>Transcriptional Activation</subject><subject>Tumor Suppressor Proteins</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkUtvEzEUhS0EoqGwZYm8QKhdTLA9zyxR0peUKhEUiZ3l8dzJuMzYwfaU5q_x63pDInWFsCxZtr5z7vU9hLznbMpZmX2-r_X0NmUsrUrB2Asy4axKkzTnP16SCWOCJzORVyfkTQj3DFc246_JCRf5LM9FMSF_1t4NO-id3kWj6RLGnzAYRfE5grH0bH27PKeXo9XROBuowk2v-lE77TwqnGnoV9Cwjc7TuUsUcg9qf6l39Bv8GiFE8MZu6EI9PtLoaOyAoildWe02YLHowg3KoPfZerUI53vmwnbKaqA3MdA7r2w42mILdI2N2WhU_5a8alUf4N3xPCXfLy_u5tfJcnV1M_-yTHTOipgUDNJWzErgDeNZplqVlWnLa80qKETWlG3NOWgcVdroVhVtVagMWs5Fo2eiTtNT8ungu_Xu73_kYIKGvlcW3BhkmaJUsOy_IK8QLYq94_QAau9C8NDKrTeD8jvJmdzHKjFW-RwrCj4cncd6gOYZP-aIwMcD0JlN99t4kLVxuoNBirLCwpIjWCFWHTDAeT0Y8DJoAzjpBiU6ysaZf7XwBDjuvyI</recordid><startdate>20030502</startdate><enddate>20030502</enddate><creator>Lin, Ding-Yen</creator><creator>Lai, Ming-Zong</creator><creator>Ann, David K.</creator><creator>Shih, Hsiu-Ming</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>20030502</creationdate><title>Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential</title><author>Lin, Ding-Yen ; Lai, Ming-Zong ; Ann, David K. ; Shih, Hsiu-Ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adaptor Proteins, Signal Transducing</topic><topic>Animals</topic><topic>Arsenic Trioxide</topic><topic>Arsenicals - pharmacology</topic><topic>Carrier Proteins - chemistry</topic><topic>Carrier Proteins - physiology</topic><topic>Co-Repressor Proteins</topic><topic>COS Cells</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Mammary Tumor Virus, Mouse - genetics</topic><topic>Molecular Chaperones</topic><topic>Neoplasm Proteins - physiology</topic><topic>Nuclear Proteins - chemistry</topic><topic>Nuclear Proteins - physiology</topic><topic>Oxides - pharmacology</topic><topic>Promoter Regions, Genetic</topic><topic>Promyelocytic Leukemia Protein</topic><topic>Receptors, Glucocorticoid - physiology</topic><topic>Transcription Factors - physiology</topic><topic>Transcriptional Activation</topic><topic>Tumor Suppressor Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Ding-Yen</creatorcontrib><creatorcontrib>Lai, Ming-Zong</creatorcontrib><creatorcontrib>Ann, David K.</creatorcontrib><creatorcontrib>Shih, Hsiu-Ming</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Ding-Yen</au><au>Lai, Ming-Zong</au><au>Ann, David K.</au><au>Shih, Hsiu-Ming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2003-05-02</date><risdate>2003</risdate><volume>278</volume><issue>18</issue><spage>15958</spage><epage>15965</epage><pages>15958-15965</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumor virus promoter in COS-1, HeLa, and 293T cells. In vitro and in vivo studies revealed that Daxx could directly bind to GR. The mapping analysis further demonstrated that the C-terminal region of Daxx-(501–740) mediates the interaction and transcriptional repression of GR. The repressive effect of Daxx and Daxx-(501–740) on GR could be alleviated by co-expression of promyelocytic leukemia protein (PML). Furthermore, immunofluorescence analysis showed that overexpression of wild-type PML results in the translocation of Daxx and Daxx-(501–740) to the PML oncogenic domains (PODs). By contrast, a PML sumoylation-defective mutant failed to recruit Daxx to PODs and to reverse the Daxx repression effect on GR. Accordingly, As2O3 treatment rendered the sequestration of endogenous Daxx to the PODs, leading to an enhancement of GR transactivation in COS-1 cells. Taken together, these findings suggest that recruitment of Daxx into the subnuclear POD structures sequesters it from the GR/co-activators complex, thereby alleviating its repressive effects. Our present studies provide the important link between Daxx/PML interaction and GR transcriptional activation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>12595526</pmid><doi>10.1074/jbc.M300387200</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2003-05, Vol.278 (18), p.15958-15965 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_proquest_miscellaneous_73213204 |
source | ScienceDirect (Online service) |
subjects | Adaptor Proteins, Signal Transducing Animals Arsenic Trioxide Arsenicals - pharmacology Carrier Proteins - chemistry Carrier Proteins - physiology Co-Repressor Proteins COS Cells HeLa Cells Humans Intracellular Signaling Peptides and Proteins Mammary Tumor Virus, Mouse - genetics Molecular Chaperones Neoplasm Proteins - physiology Nuclear Proteins - chemistry Nuclear Proteins - physiology Oxides - pharmacology Promoter Regions, Genetic Promyelocytic Leukemia Protein Receptors, Glucocorticoid - physiology Transcription Factors - physiology Transcriptional Activation Tumor Suppressor Proteins |
title | Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A39%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Promyelocytic%20Leukemia%20Protein%20(PML)%20Functions%20as%20a%20Glucocorticoid%20Receptor%20Co-activator%20by%20Sequestering%20Daxx%20to%20the%20PML%20Oncogenic%20Domains%20(PODs)%20to%20Enhance%20Its%20Transactivation%20Potential&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Lin,%20Ding-Yen&rft.date=2003-05-02&rft.volume=278&rft.issue=18&rft.spage=15958&rft.epage=15965&rft.pages=15958-15965&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M300387200&rft_dat=%3Cproquest_cross%3E73213204%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18732663&rft_id=info:pmid/12595526&rfr_iscdi=true |